Nuvation Bio Income Statement (2020-2026) | NUVB

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
0.35M
Revenue & cost
Revenue (Quarter)
1.44M0.73M5.71M3.08M4.83M13.12M41.87M83.23M31.69M
Gross Profit (Quarter)
0.09M-0.79M1.50M0.99M2.26M9.77M49.03M82.85M30.78M
Operating items
Research & Development (Quarter)
17.12M22.00M20.73M28.92M21.29M16.87M18.79M18.59M18.56M15.35M12.84M29.25M27.73M29.30M24.60M27.36M28.85M34.30M35.05M30.66M
Wages, Salaries and Other (Quarter)
0.17M0.19M0.17M0.21M0.26M0.23M0.23M0.23M0.23M0.26M0.27M0.25M0.24M0.23M0.20M0.18M0.17M0.17M0.20M0.18M
Selling, General & Administrative (Quarter)
5.67M7.61M7.46M8.95M8.04M7.46M7.73M7.54M7.78M5.48M7.36M16.16M19.58M26.14M35.39M38.48M37.36M40.33M38.31M42.59M
Other Operating Expenses (Quarter)
2.09M-0.03M0.00M-0.00M5.99M0.00M
Operating Expenses (Quarter)
22.79M29.61M28.19M37.87M29.34M24.34M26.52M26.13M26.34M20.83M20.20M470.47M47.31M62.52M62.09M65.85M66.20M83.92M79.35M82.72M
Operating Income (Quarter)
-22.79M-29.61M-28.19M-37.87M-29.34M-24.34M-26.52M-26.13M-26.34M-20.83M-20.20M-470.38M-48.10M-53.94M-59.00M-63.59M-56.43M-34.04M3.88M-51.04M
EBIT (Quarter)
-22.79M-29.61M-28.19M-37.87M-29.34M-24.34M-26.52M-26.13M-26.34M-20.83M-20.20M-470.38M-48.10M-53.94M-59.00M-63.59M-56.43M-34.04M3.88M-51.04M
Non-operating items
Non Operating Investment Income (Quarter)
-0.10M0.01M0.04M0.00M-0.01M-0.01M0.01M0.00M-0.00M0.00M0.01M0.01M
Interest & Investment Income (Quarter)
0.85M0.90M0.96M0.84M2.13M3.52M4.98M6.09M6.52M7.02M7.13M7.14M6.73M6.06M5.32M4.78M6.03M5.30M5.11M4.60M
Other Non Operating Income (Quarter)
-9.47M
Non Operating Income (Quarter)
0.81M4.47M6.90M3.01M2.13M3.49M4.79M5.49M6.69M7.04M5.41M7.89M6.89M4.50M5.77M4.58M0.64M-2.56M1.52M-11.80M
Net income details
EBT (Quarter)
-21.98M-25.13M-21.29M-34.86M-27.20M-20.84M-21.73M-20.64M-19.65M-13.79M-14.79M-462.49M-41.21M-49.45M-53.24M-59.01M-55.79M-36.59M5.40M-62.84M
Tax Provisions (Quarter)
-41.69M
Profit After Tax (Quarter)
-63.77M
Income from Continuing Operations (Quarter)
-62.84M
Consolidated Net Income (Quarter)
-62.84M
Income towards Parent Company (Quarter)
-62.84M
Net Income towards Common Stockholders (Quarter)
-62.84M
Additional items
EPS (Basic) (Quarter)
-180.18
EPS (Diluted) (Quarter)
-180.18
Shares Outstanding (Quarter)
0.35M
Shares Outstanding (Diluted) (Quarter)
0.35M
EBITDA (Quarter)
-51.04M
Interest Expenses (Quarter)
6.76M
Tax Rate (Quarter)
113.93